{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T06:03:46Z","timestamp":1748930626217},"reference-count":39,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,7,6]],"date-time":"2009-07-06T00:00:00Z","timestamp":1246838400000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Review"],"published-print":{"date-parts":[[2009,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p> <jats:italic>\n            <jats:bold>Introduction and Aims.<\/jats:bold> The prevalence of hepatitis C virus (HCV) among heroin dependants in treatment was estimated at 89.9%; however, virtually no information exists on the prevalence or risk behaviour among the larger population of drug users not in treatment. This study assessed the prevalence of HCV and associated risk factors among this group with a view to designing more effective intervention programs. <jats:bold>Design and Methods.<\/jats:bold> A cross\u2010sectional survey of 552 not\u2010in\u2010treatment drug users recruited from five key urban centres across peninsular Malaysia with on\u2010site serological testing for HCV and HIV seropositivity was conducted. <jats:bold>Results.<\/jats:bold> HCV prevalence was 65.4% for the overall sample, but higher among injecting drug users (67.1%) relative to non\u2010injecting drug users (30.8%). Bivariate analysis suggested seven risk factors though only sharing injecting paraphernalia and lifetime homosexual\/bisexual behaviour remained significant in multivariate analysis. <jats:bold>Discussion and Conclusions.<\/jats:bold> With the majority (65.9%) sharing injecting equipment and about the same proportion (65.4%) being HCV positive, the risk of further transmission to new drug users is high. It is imperative that the nascent needle and syringe exchange and condom distribution program and its ancillary services\u2014launched in 2005 to fight HIV\u2014be fine tuned, as a first step, to control HCV. With its greater infectivity and non\u2010symptomatic character, HCV is more insidious. Given the shared risk factors of HCV and HIV, routine screening of drug users for HCV\u2014currently non\u2010existent\u2014should be instituted. This, with other intervention measures, will help detect and control HCV at an earlier stage while also checking the spread of HIV.<\/jats:italic>[Vicknasingam B, Narayanan S, Navaratnam V. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia. <jats:italic>Drug Alcohol Rev<\/jats:italic> 2009;28:447\u2013454]<\/jats:p>","DOI":"10.1111\/j.1465-3362.2009.00087.x","type":"journal-article","created":{"date-parts":[[2010,8,16]],"date-time":"2010-08-16T11:10:55Z","timestamp":1281957055000},"page":"447-454","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia"],"prefix":"10.1111","volume":"28","author":[{"given":"BALASINGAM","family":"VICKNASINGAM","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SURESH","family":"NARAYANAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"VISWESWARAN","family":"NAVARATNAM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,7,6]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2007.04.004"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-004-3063-7"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61116-2"},{"key":"e_1_2_8_5_2","volume-title":"Laporan Dadah, 2007; 3, January\u2013September","author":"Agensi Anti\u2010Dadah Kebangsaan (AADK)","year":"2007"},{"key":"e_1_2_8_6_2","unstructured":"Ministry of Health.Speech of YB Datuk Seri Dr Chua Soi Lek Minister of Health Malaysia at the United Nations World AIDS Day 2006 Commemoration Kuala Lumpur 30 November 2006. Available at:http:\/\/www.moh.gov.my\/MohPortal\/DownloadServlet?id=1047&type=2(accessed 7 April 2008)."},{"key":"e_1_2_8_7_2","unstructured":"Ministry of Health.Speech of YB Datuk Seri Dr Chua Soi Lek Minister of Health Malaysia at the opening ceremony and launch of clinical practice guidelines Liver update 2007 12 July 2007. Available athttp:\/\/www.moh.gov.my\/MohPortal\/DownloadServlet?id=411&type=2(accessed 7 April 2008)."},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7136.989"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(01)01488-0"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.19.1690"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2006.11.004"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(00)00161-7"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2007.10.001"},{"key":"e_1_2_8_14_2","volume-title":"Statistical methods for the social sciences","author":"Agrest A","year":"1999"},{"key":"e_1_2_8_15_2","first-page":"359","article-title":"Computer and student learning: bivariate and multivariate evidence on the availability and use of computers at home and at school","volume":"47","author":"Fuchs T","year":"2004","journal-title":"Brussels Econ Rev"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2007.08.011"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2006.74.1111"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-10-200605160-00004"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/155.7.645"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2008.01.014"},{"key":"e_1_2_8_21_2","first-page":"253","article-title":"Hepatitis C virus infection and risk behaviours among injecting drug users of Nagaland","volume":"26","author":"Das HK","year":"2007","journal-title":"Indian J Gastroenterol"},{"key":"e_1_2_8_22_2","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.3748\/wjg.v12.i30.4884","article-title":"Seroepidemiology of hepatitis C and its risk factors in Khuzestan Province, south\u2010west of Iran: a case\u2010control study","volume":"14","author":"Hajiani E","year":"2006","journal-title":"World J Gastroenterol"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1080\/10647440300025520"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1086\/429491"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(06)80008-6"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/jurban\/jtg137"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1080\/09595230500102673"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.12.035"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-3959(03)00137-3"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-3959(02)00092-0"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2007.01.013"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.91.1.42"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-3959(00)00069-4"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(06)80006-2"},{"key":"e_1_2_8_35_2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1023\/A:1007622831518","article-title":"HIV status knowledge and risk behaviours among intravenous drug users","volume":"16","author":"Vidal\u2010Trecan G","journal-title":"Eur J Epidemiol"},{"key":"e_1_2_8_36_2","first-page":"889","article-title":"Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection","volume":"165","author":"Patrick DM","year":"2001","journal-title":"Canad Med Assoc J"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2007.01.003"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1753-6405.2007.00007.x"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007662315835"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2007.06.001"}],"container-title":["Drug and Alcohol Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1465-3362.2009.00087.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1465-3362.2009.00087.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T15:53:23Z","timestamp":1696953203000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1465-3362.2009.00087.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["10.1111\/j.1465-3362.2009.00087.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1465-3362.2009.00087.x","archive":["Portico"],"relation":{},"ISSN":["0959-5236","1465-3362"],"issn-type":[{"value":"0959-5236","type":"print"},{"value":"1465-3362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7]]},"assertion":[{"value":"2009-07-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}